FDA
approval
· 2022-04-27
FDA Approved: RANOLAZINE — Original Application (A2A Integrated Pharmaceuticals)
Summary
FDA approves the original ANDA for Ranolazine submitted by A2A Integrated Pharmaceuticals.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RANOLAZINE (RANOLAZINE)